We are a proposal-based contract lab.
We are constantly working on developing new models.
This page provides information about models currently in development as well as models that are already available.
List of Research and Development
| Field | Subject | Under development | Study available |
|---|---|---|---|
| Infection | Establishment of an infection model using a novel influenza virus | ◎ | |
| Central nervous system | Establishment of a behavioral assessment system in a germ-free environment | ◎ | |
| Central nervous system | Establishment of tau protein immunostaining conditions in the brain of a tau propagation model | ◎ | |
| Central nervous system | Acquisition of immunostaining methods of the spinal cord in a spinal cord injury model and pathological evaluation of spinal cord injury | ◎ | |
| Central nervous system | Establishment of administration and sample collection techniques using intrathecal and intraportal catheters | ○ | |
| Central nervous system | Establishment of an experimental autoimmune encephalomyelitis (EAE) induction model using Hooke Kit MOG35-55 | ○ | |
| Central nervous system | Establishment of measurement conditions of retinal and visual evoked potentials and intraspinal administration method in an aged animal model | ○ | |
| Central nervous system | Establishment of an experimental system of novel environment-induced feeding suppression test | ○ | |
| Ophthalmology | Establishment of a dry eye model | ○ | |
| Ophthalmology | Establishment of a novel open angle glaucoma model | ○ | |
| in vitro | Establishment of an in vitro hemolytic assay using Henke-Ject disposable syringes | ◎ | |
| in vitro | Establishment of techniques for ocular irritation assessment in the LabCyte CORNEA-MODEL | ◎ | |
| in vitro | Establishment of in vitro blood compatibility testing using human blood | ○ | |
| Experimental techniques | Establishment of techniques for oocyte retrieval using tubal cannulation | ○ | |
| Examination | Establishment of a measurement method of rat thyroid-stimulating hormone using Luminex | ◎ | |
| Examination | Confirmation of the impact of microsampling on blood parameters | ◎ | |
| Infection | Establishment of an airborne transmission model of influenza | ◎ | |
| Infection | Establishment of a rotavirus infection model | ◎ | |
| Infection | Establishment of a urinary tract infection model | ◎ | |
| Infection | Establishment of a fungal keratitis model | ◎ | |
| Central nervous system | Establishment of an epilepsy seizure model | ◎ | |
| Central nervous system | Establishment of a single administration model of Aβ1-42 | ◎ | |
| Central nervous system | Establishment of a tau propagation model | ◎ | |
| Central nervous system | Establishment of a sleep disorder model | ◎ | |
| Central nervous system | Establishment of a synuclein propagation model | ◎ | |
| Central nervous system | Establishment of an autism model induced by environmental factors | ◎ | |
| Central nervous system | Establishment of a cell-based assay for Alzheimer's disease model | ◎ | |
| Central nervous system | Establishment of an autism-like model by propionic acid administration | ◎ | |
| Central nervous system | Establishment of a tau and synuclein propagation model using SH-SY5Y cells | ○ | |
| Auditory | Establishment of an age-related hearing loss model | ○ | |
| Auditory | Establishment of a cisplatin-induced hearing loss model | ○ | |
| Auditory | Establishment of an in vitro auditory oxidative stress model using HEI-OC1 cells | ○ | |
| Respiratory diseases | Establishment of a chronic obstructive pulmonary disease (COPD) model | ◎ | |
| Respiratory diseases | Establishment of a haloperidol-induced dysphagia model | ◎ | |
| Respiratory diseases | Establishment of a capsaicin-induced cough model | ◎ | |
| Liver diseases | Establishment of a non-alcoholic steatohepatitis (NASH) model | ◎ | |
| Liver diseases | Establishment of a short-term onset non-alcoholic steatohepatitis (NASH) model | ◎ | |
| Liver diseases | Establishment of a thioacetamide-induced liver fibrosis model | ○ | |
| Renal diseases | Establishment of a model of fibrosis following ischemic acute kidney injury | ◎ | |
| Renal diseases | Establishment of a model of transition from acute kidney injury to chronic kidney disease | ◎ | |
| Renal diseases | Evaluation of vascular calcification after chronic hemodialysis using Göttingen minipigs | ○ | |
| Renal diseases | 5/6 nephrectomy and high-phosphate diet loading using Göttingen minipigs | ○ | |
| Renal diseases | Establishment of a cisplatin-induced renal impairment model | ○ | |
| Skin | Data acquisition of skin irritancy of various vehicles for adhesive agents in LabCyte EPI-MODEL24 | ◎ | |
| Skin | Establishment of a skin fibrosis model | ○ | |
| Gastrointestinal diseases | Establishment of a dextran sodium sulfate (DSS)-induced colitis model | ◎ | |
| Aging (menopause) | Establishment of an aged model of sarcopenia and cognitive decline | ◎ | |
| Aging (cancer) | Anti-tumor efficacy testing on DMBA-induced mammary tumors | ○ | |
| Aging (cancer) | Background data acquisition of mid-term skin carcinogenicity testing | ○ | |
| Aging (cancer) | Establishment of an evaluation system for carcinogenic promotion effect using an inflammatory colorectal cancer model | ○ | |
| Aging | Establishment of a male menopause model | ○ | |
| Regenerative medicine products | Establishment of a spinal cord injury model | ◎ | |
| Medical devices | Confirmation of reactivity of positive control substances in hemolytic assays –direct contact method and extraction method– | ◎ | |
| in vitro | Establishment of a cytotoxicity assay using V79 cells (test on extracts) | ◎ | |
| in vitro | Ocular irritation assessment using LabCyte CORNEA-MODEL | ◎ | |
| in vitro | Membrane permeability assay using Ready Cell | ○ | |
| Ames test | Establishment of the Enhanced Ames Test (EAT) | ○ |